[Federal Register Volume 82, Number 73 (Tuesday, April 18, 2017)]
[Notices]
[Pages 18305-18306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meetings

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the Task 
Force on Research Specific to Pregnant Women and Lactating Women.
    The meetings will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Task Force on Research Specific to Pregnant 
Women and Lactating Women.
    Date: August 21-22, 2017.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: The Task Force is charged with providing advice and 
guidance to the Secretary of HHS, regarding Federal activities 
related to identifying and addressing gaps in knowledge and research 
regarding safe and effective therapies for pregnant women and 
lactating women, including the development of such therapies and the 
collaboration on and coordination of such activities.
    Place: National Institutes of Health, Building 31, C-Wing, 
Conference Rm. 6, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice 
Kennedy Shriver National Institute of Child Health and Human 
Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD 
20892, (301) 496-0536, [email protected].

    Name of Committee: Task Force on Research Specific to Pregnant 
Women and Lactating Women.
    Date: November 6-7, 2017.
    Time: 8:00 a.m. to 5:30 p.m.
    Agenda: The Task Force is charged with providing advice and 
guidance to the Secretary of HHS, regarding Federal activities 
related to identifying and addressing gaps in knowledge and research 
regarding safe and effective therapies for pregnant women and 
lactating women, including the development of such therapies and the 
collaboration on and coordination of such activities.
    Place: National Institutes of Health, Conference Rm. C-D, 6001 
Executive Blvd., Rockville, MD 20852.
    Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice 
Kennedy Shriver National Institute of Child Health and Human

[[Page 18306]]

Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD 
20892, (301) 496-0536, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: April 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07739 Filed 4-17-17; 8:45 am]
 BILLING CODE 4140-01-P